Dogwood Therapeutics, Inc.
DWTX
$6.21
-$0.01-0.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.83% | -32.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 302.97% | -11.44% | |||
| Operating Income | -302.97% | 11.44% | |||
| Income Before Tax | -313.59% | 64.53% | |||
| Income Tax Expenses | -1,500.00% | -99.95% | |||
| Earnings from Continuing Operations | -313.53% | 65.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -313.53% | 65.15% | |||
| EBIT | -302.97% | 11.44% | |||
| EBITDA | -304.73% | 11.49% | |||
| EPS Basic | -311.74% | 76.42% | |||
| Normalized Basic EPS | -311.79% | 37.57% | |||
| EPS Diluted | -311.74% | 76.42% | |||
| Normalized Diluted EPS | -311.79% | 37.57% | |||
| Average Basic Shares Outstanding | 0.43% | 32.58% | |||
| Average Diluted Shares Outstanding | 0.43% | 32.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||